US Stock MarketDetailed Quotes

BDMDW BAIRD MEDICAL INVESTMENT HLDGS LTD C/WTS 01/10/2029 (TO PUR COM)

Watchlist
  • 0.048
  • +0.008+20.91%
Close Oct 31 16:00 ET
  • 0.048
  • 0.0000.00%
Pre 04:03 ET
0Market Cap0.00P/E (TTM)

BAIRD MEDICAL INVESTMENT HLDGS LTD C/WTS 01/10/2029 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
-10.35%31.46M
26.58%35.09M
27.72M
Operating revenue
-10.35%31.46M
26.58%35.09M
--27.72M
Cost of revenue
-40.07%4.23M
55.24%7.05M
4.54M
Gross profit
-2.88%27.23M
20.96%28.04M
23.18M
Operating expense
11.87%14.58M
29.19%13.03M
10.09M
Selling and administrative expenses
5.20%11.09M
3.18%10.55M
--10.22M
-Selling and marketing expense
-28.96%2.55M
0.43%3.59M
--3.57M
-General and administrative expense
22.79%8.55M
4.65%6.96M
--6.65M
Research and development costs
10.77%4.27M
271.08%3.86M
--1.04M
Other operating expenses
42.42%-791.96K
-17.06%-1.38M
---1.18M
Operating profit
-15.68%12.65M
14.63%15.01M
13.09M
Net non-operating interest income expense
2.22%-284.27K
-91.77%-290.72K
-151.6K
Non-operating interest income
-81.74%1.56K
267.71%8.55K
--2.33K
Non-operating interest expense
-4.49%285.83K
94.43%299.27K
--153.92K
Other net income (expense)
94.75%-10.21K
41.93%-194.58K
-335.08K
Other non- operating income (expenses)
94.75%-10.21K
41.93%-194.58K
---335.08K
Income before tax
-14.89%12.36M
15.20%14.52M
12.61M
Income tax
-2.63%1.7M
-27.89%1.75M
2.42M
Net income
-16.57%10.66M
25.45%12.77M
10.18M
Net income continuous Operations
-16.57%10.66M
25.45%12.77M
--10.18M
Minority interest income
-45.59%112.21K
119.47%206.22K
93.97K
Net income attributable to the parent company
-16.09%10.55M
24.58%12.57M
10.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.09%10.55M
24.58%12.57M
10.09M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue -10.35%31.46M26.58%35.09M27.72M
Operating revenue -10.35%31.46M26.58%35.09M--27.72M
Cost of revenue -40.07%4.23M55.24%7.05M4.54M
Gross profit -2.88%27.23M20.96%28.04M23.18M
Operating expense 11.87%14.58M29.19%13.03M10.09M
Selling and administrative expenses 5.20%11.09M3.18%10.55M--10.22M
-Selling and marketing expense -28.96%2.55M0.43%3.59M--3.57M
-General and administrative expense 22.79%8.55M4.65%6.96M--6.65M
Research and development costs 10.77%4.27M271.08%3.86M--1.04M
Other operating expenses 42.42%-791.96K-17.06%-1.38M---1.18M
Operating profit -15.68%12.65M14.63%15.01M13.09M
Net non-operating interest income expense 2.22%-284.27K-91.77%-290.72K-151.6K
Non-operating interest income -81.74%1.56K267.71%8.55K--2.33K
Non-operating interest expense -4.49%285.83K94.43%299.27K--153.92K
Other net income (expense) 94.75%-10.21K41.93%-194.58K-335.08K
Other non- operating income (expenses) 94.75%-10.21K41.93%-194.58K---335.08K
Income before tax -14.89%12.36M15.20%14.52M12.61M
Income tax -2.63%1.7M-27.89%1.75M2.42M
Net income -16.57%10.66M25.45%12.77M10.18M
Net income continuous Operations -16.57%10.66M25.45%12.77M--10.18M
Minority interest income -45.59%112.21K119.47%206.22K93.97K
Net income attributable to the parent company -16.09%10.55M24.58%12.57M10.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.09%10.55M24.58%12.57M10.09M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data